StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the stock.
TherapeuticsMD Price Performance
Shares of TXMD opened at $1.72 on Monday. The business’s 50-day moving average price is $1.76 and its 200 day moving average price is $1.96. TherapeuticsMD has a 1-year low of $1.43 and a 1-year high of $3.35.
TherapeuticsMD (NASDAQ:TXMD – Get Free Report) last released its earnings results on Monday, August 12th. The company reported ($0.09) earnings per share for the quarter. The firm had revenue of $0.23 million for the quarter.
Institutional Inflows and Outflows
TherapeuticsMD Company Profile
TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.
Further Reading
- Five stocks we like better than TherapeuticsMD
- Where Do I Find 52-Week Highs and Lows?
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- NYSE Stocks Give Investors a Variety of Quality Options
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.